Savient Pharmaceuticals Inc
SVNT dipped 2.87% to $20.00 in the pre-market session. SVNT drug, Krystexxa, was approved by the Food and Drug Administration.
Crucell NV
CRXL lost 0.53% to $31.85 in the pre-market session.CRXL had announced its acquisition by Johnson & Johnson
JNJ
.
Xilinx Inc
XLNX slipped 0.08% to $26.43 in the pre-market trading. XLNX demonstrated, at Intel Developer Forum, Intel QuickPath Technology for FPGAs.
Research In Motion Limited
RIMM fell 0.06% to $46.69 in the pre-market session.RIMM had reported strong Q2 earnings.
Read more
from Benzinga's Company news.Loading...
Loading...
JNJJohnson & Johnson
$152.780.11%
Edge Rankings
Momentum
Not Available
Growth
50.07
Quality
13.13
Value
23.94
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
